# GLP‐1 receptor agonists for prevention of cardiorenal outcomes in type 2 diabetes: An updated meta‐analysis including the REWIND and PIONEER 6 trials

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/glp-1-receptor-agonists-for-prevention-of-cardiorenal-outcomes-in-type-2/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Dario Giugliano,Maria Ida Maiorino,Giuseppe Bellastella,Miriam Longo,Paolo Chiodini,Katherine Esposito |
| Citations | 150 |
| DOI | 10.1111/dom.13847 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2964932552 |
| PMID | 31373167 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Miriam Longo](https://scholariq.org/researchers/miriam-longo/)

## Paper journal

- [Diabetes Obesity and Metabolism](https://scholariq.org/journals/diabetes-obesity-and-metabolism/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.